Thirumalai Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thirumalai Chemicals reported weak Q1 FY26 results (quarter ended June 30, 2025). Standalone revenue from operations fell to ₹44,550 lakhs from ₹57,821 lakhs in Q4 FY25 and ₹53,364 lakhs in Q1 FY25, a YoY decline of about 16.5%. The company swung to a standalone loss before tax of ₹1,818 lakhs (vs profit of ₹3,808 lakhs YoY) and a loss after tax of ₹1,383 lakhs, translating to a loss per share of ₹1.35. Consolidated performance was even weaker, with revenue of ₹45,005 lakhs and a loss after tax of ₹5,996 lakhs (vs profit of ₹509 lakhs YoY), driven by losses at subsidiaries including TCL Specialties LLC. The board approved increasing the investment limit in US step-down subsidiary TCL Specialties LLC from USD 105 million to USD 165 million. The Company Secretary R. Pramod Kumar resigned effective August 18, 2025 (replaced by Aditya Sharma), and Non-Executive Director R. Sampath also resigned for personal reasons. The auditor (Walker Chandiok & Co LLP) issued an unmodified limited review report.
Shareholders should note a sharp deterioration in profitability with both standalone and consolidated businesses reporting losses, and an increased capital commitment to the loss-making US subsidiary which could pressure cash flows. The sudden loss and rising investment in TCL Specialties LLC may weigh on near-term sentiment, though the board is clearly betting on a turnaround at the subsidiary.